Difference in change from baseline in metabolic and liver parameters for the maraviroc + OBT versus OBT group with bootstrapped 95% confidence intervals.
LCL, lower confidence limit; UCL upper confidence limitSupplementary Table S4 in For QoL outcomes, comparing change from baseline through weeks 48 and 96 between treatment groups, 95% CI were wide indicating imprecise estimation of between-group differences. In all cases, 95% CI included zero, consistent with there being no detectable between-group differences (